Cover Image

Incanthera Ltd.:產品平台分析

Incanthera Ltd. - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 339672
出版日期 內容資訊 英文 19 Pages
Back to Top
Incanthera Ltd.:產品平台分析 Incanthera Ltd. - Product Pipeline Review - 2015
出版日期: 2015年08月12日 內容資訊: 英文 19 Pages

Incanthera Ltd. 是致力於開發癌症治療藥的生物製藥公司。該公司正在與the Institute of Cancer Therapeutics及the University of Salford等外部研究機關合作開發候補藥。此外也支援the University of Bradford's Institute of Cancer Therapeutics 所開發的新藥商品化。

本報告提供Incanthera Ltd.的治療藥開發平台現狀及各開發階段比較分析,提供您藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,最新的企業新聞和發表,後期階段及中止的計劃等相關資訊。

Incanthera Ltd.的基本資料

  • Incanthera Ltd.概要
  • 主要資訊
  • 企業資料

Incanthera Ltd.:R&D概要

  • 主要的治療範圍

Incanthera Ltd.:開發平台評估

  • 各開發階段的開發中產品
  • 單劑產品

Incanthera Ltd.:開發中產品概況

  • 初期階段的開發中產品
    • 前臨床階段的產品/聯合治療模式
    • 藥物研發中的產品/聯合治療模式

Incanthera Ltd.:藥物簡介

  • ICT-03Es5
  • ICT-2588
  • Small Molecules for Cancer
  • Pd(II) for Cancer

Incanthera Ltd.:開發平台分析

  • 各分子類型

Incanthera Ltd.:總公司和子公司的所在地



Product Code: GMDHC07495CDB


Global Markets Direct's, 'Incanthera Ltd. - Product Pipeline Review - 2015', provides an overview of the Incanthera Ltd.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Incanthera Ltd.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.


  • The report provides brief overview of Incanthera Ltd. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Incanthera Ltd.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Incanthera Ltd.'s pipeline products

Reasons to buy

  • Evaluate Incanthera Ltd.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Incanthera Ltd. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Incanthera Ltd.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Incanthera Ltd. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Incanthera Ltd.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Incanthera Ltd. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Incanthera Ltd. Snapshot
    • Incanthera Ltd. Overview
    • Key Information
    • Key Facts
  • Incanthera Ltd. - Research and Development Overview
    • Key Therapeutic Areas
  • Incanthera Ltd. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • Incanthera Ltd. - Pipeline Products Glance
    • Incanthera Ltd. - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
      • Discovery Products/Combination Treatment Modalities
  • Incanthera Ltd. - Drug Profiles
    • ICT-03Es5
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • ICT-2588
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecules for Cancer
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Pd(II) for Cancer
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Incanthera Ltd. - Pipeline Analysis
  • Incanthera Ltd. - Pipeline Products by Molecule Type
  • Incanthera Ltd. - Locations And Subsidiaries
    • Head Office
    • Other Locations & Subsidiaries
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Incanthera Ltd., Key Information
  • Incanthera Ltd., Key Facts
  • Incanthera Ltd. - Pipeline by Indication, 2015
  • Incanthera Ltd. - Pipeline by Stage of Development, 2015
  • Incanthera Ltd. - Monotherapy Products in Pipeline, 2015
  • Incanthera Ltd. - Preclinical, 2015
  • Incanthera Ltd. - Discovery, 2015
  • Incanthera Ltd. - Pipeline by Molecule Type, 2015
  • Incanthera Ltd., Other Locations
  • Incanthera Ltd., Subsidiaries

List of Figures

  • Incanthera Ltd. - Pipeline by Top 10 Indication, 2015
  • Incanthera Ltd. - Pipeline by Stage of Development, 2015
  • Incanthera Ltd. - Monotherapy Products in Pipeline, 2015
  • Incanthera Ltd. - Pipeline by Top 10 Molecule Type, 2015
Back to Top